Table 1 Patients’ characteristics (n = 54)

Median age, years (range)

72 (55–89)

Median observation period, months (range)

21.4 (0.9–57.8)

Median PSA, ng/mL (range)

247.0 (9.7–4206.0)

PSA distribution, n (%)

 <10 ng/mL

1 (1.7)

 10- < 20 ng/mL

2 (3.3)

 20- < 100 ng/mL

15 (25.0)

 100- < 500 ng/mL

20 (33.3)

 ≥500 ng/mL

22 (36.7)

Gleason scores, n (%)

 ≤6

0 (0.0)

 7

7 (11.7)

 8

24 (40.0)

 9

19 (31.7)

 10

10 (16.7)

T stage, n (%)

 T1

0 (0.0)

 T2

1 (1.7)

 T3

43 (71.7)

 T4

16 (26.7)

N stage, n (%)

 N0

24 (40.0)

 N1

36 (60.0)

M stage, n (%)

 M1b

51 (85.0)

 M1c

9 (15.0)

Median BSI, % (range)

1.9 (0.0–13.2)

EOD, n (%)

 1

21 (35.0)

 2

20 (33.3)

 3

15 (25.0)

 4

4 (6.7)